Gentera raises full-year guidance after strong Q2 performance

Gentera SAB de CV reported robust second-quarter results, with net income of MXN2.1 billion, up 77% year-over-year and exceeding Bloomberg consensus by 10%. The company achieved a consolidated return on equity of 25.9% and 21.6% loan growth, while non-performing loan formation declined to a 12-month low of 10.8%. Following this strong performance, Gentera raised its full-year 2025 earnings per share guidance by approximately 10% to MXN5.0-5.15, now surpassing the current Bloomberg consensus of MXN4.89, indicating a positive outlook.

Analysis

Gentera SAB de CV (BMV:GENTERA) reported a strong second quarter, with net income surging 77% year-over-year to MXN2.1 billion, exceeding Bloomberg consensus estimates by 10%. The company's profitability is robust, demonstrated by a consolidated return on equity (ROE) of 25.9%, with strong performance from its Mexico (30.8% ROE) and Peru (22.7% ROE) units. This earnings power is supported by vigorous consolidated loan growth of 21.6%. A key positive development is the improvement in asset quality, as consolidated non-performing loan (NPL) formation decreased to a 12-month low of 10.8%; the Peru division's NPL formation notably improved to 9.8% from a peak of 15.6%. However, the NPL formation at the Concredito unit remains an outlier at an elevated 23.6%. Reflecting this strong performance, management raised its full-year 2025 EPS guidance by approximately 10% to a new range of MXN5.0-5.15, which now sits above the current consensus of MXN4.89 and implies significant year-over-year growth of 31-35%.

Key Decisions for Investors

• The combination of a 10% earnings beat, robust 21.6% loan growth, and upgraded EPS guidance that surpasses consensus signals strong operational momentum, which could serve as a positive catalyst for the stock.
• Investors should monitor the elevated non-performing loan formation of 23.6% at the Concredito unit, as this remains a specific risk factor that could impact consolidated asset quality if not contained.
• The new EPS guidance provides a higher benchmark for valuation, and investors should anticipate upward revisions to analyst estimates and price targets based on the company's improved outlook.